THB ASSET MANAGEMENT - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
THB ASSET MANAGEMENT ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$745,000
+1.5%
31,442
+17.7%
0.14%
+1.5%
Q3 2019$734,000
-18.8%
26,714
-2.2%
0.14%
-5.6%
Q2 2019$904,000
-5.5%
27,3260.0%0.14%
+3.6%
Q1 2019$957,000
+6.0%
27,326
+0.4%
0.14%
+3.7%
Q4 2018$903,000
-34.0%
27,2040.0%0.13%
-20.2%
Q3 2018$1,369,000
-24.8%
27,204
-10.5%
0.17%
-24.3%
Q2 2018$1,820,000
+34.5%
30,410
+2.9%
0.22%
+25.4%
Q1 2018$1,353,000
+19.0%
29,556
+3.5%
0.18%
+18.0%
Q4 2017$1,137,000
+8.3%
28,556
+8.8%
0.15%
+4.2%
Q3 2017$1,050,000
-11.3%
26,251
-4.5%
0.14%
-5.9%
Q2 2017$1,184,000
+34.5%
27,478
-2.3%
0.15%
+39.1%
Q1 2017$880,000
+23.9%
28,1280.0%0.11%
+25.0%
Q4 2016$710,000
+2.2%
28,1280.0%0.09%
-13.7%
Q3 2016$695,000
-0.1%
28,128
-17.7%
0.10%
+13.3%
Q2 2016$696,000
-22.1%
34,188
-41.6%
0.09%
-11.8%
Q1 2016$893,000
-7.6%
58,588
-18.5%
0.10%
-1.9%
Q4 2015$966,000
-75.6%
71,930
-74.5%
0.10%
-73.3%
Q3 2015$3,963,000282,4810.39%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders